Is PVNS the Same Condition as TGCT?

PVNS (Pigmented Villonodular Synovitis) is the older historical name most commonly used for what doctors now call diffuse-type TGCT (Tenosynovial Giant Cell Tumor) ^[1][2]. TGCT is the broader modern umbrella term that includes both localized and diffuse types of the disease ^[3]. If your doctor diagnosed you with PVNS but the resources you find online say TGCT, you are reading about the correct condition ^[1].

It is important to know right away that TGCT is a benign (non-cancerous) tumor ^[3]. While it can be locally aggressive and cause damage to nearby joint structures, it does not typically spread to distant organs ^[3].

Why the Name Change? The Role of Genetics

In the past, these tumors were named based on how they looked under a microscope and where they were found in the body ^[4]. However, the World Health Organization (WHO) updated the terminology to TGCT because modern genetic research revealed that these differently named tumors are part of the same disease spectrum ^[3][4].

Many TGCTs are driven by an acquired (not inherited) genetic alteration or rearrangement involving the CSF1 gene ^[4]. This alteration causes a small number of tumor cells to overproduce a protein called CSF1. This excess protein tricks healthy immune cells (like macrophages) into gathering in the joint and forming a mass ^[5]. Because of this shared underlying biology, the WHO officially grouped them together under the single name TGCT ^[3].

Translating the Old Terms to the New

While TGCT is the official medical term today, older terms are still frequently used in pathology reports and medical literature ^[1]. Here is a helpful way to understand the terminology:

• Giant Cell Tumor of the Tendon Sheath (GCTTS): Historically, this term was used for a tumor that formed a single, well-defined mass. It is typically found in a tendon sheath (the protective tunnel covering a tendon) in the fingers, toes, wrists, or ankles. Today, this is called Localized TGCT ^[6][1].
• Pigmented Villonodular Synovitis (PVNS): Historically, this term was used for tumors that were more widespread, infiltrating the tissue lining a joint (the synovium) like a carpet. This can happen in weight-bearing joints like the knee, hip, or ankle, as well as the shoulder, wrist, and other soft-tissue sites. Today, this is called Diffuse TGCT ^[6][2].

What This Means for You

The name change does not mean you have a new or more serious disease. Today, the most important distinction for your care is whether your TGCT is localized (contained in one spot) or diffuse (widespread) ^[3]. Diagnosis is ordinarily based on your clinical picture, MRI imaging, and what the cells look like under a microscope ^[7]. Genetic testing is not routinely required unless the diagnosis is uncertain ^[8].

Knowing whether your tumor is localized or diffuse helps estimate the risk of the tumor returning (recurrence) and guides treatment planning ^[4][7]. Surgery is the standard treatment, but if a diffuse tumor is difficult to safely remove or causes significant symptoms, your doctor might discuss systemic therapy (medications that work throughout the body to target the CSF1 pathway) ^[5][9]. These medications are typically reserved for specific, symptomatic situations and require careful monitoring by a specialist ^[9].